Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Mar 30, 2023, after the close
10-K filed Mar 30, 2023, 89 days after period end · 0000320017-23-000011
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$5.99M | -$6.79M | -$5.43M | -$4.96M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2022 · filed Mar 30, 2023 · 89 d after period end
+6.9% from the close of Mar 29, 2023 to the close of Mar 31, 2023, the first after the release.
